ライフサイエンスコーパス: Trichomonas vaginalis

1 ) and three partial draft genomes (including Trichomonas vaginalis).

2 (zero for bacterial vaginosis, candida, and Trichomonas vaginalis).

3 drial protist pathogens: Giardia lamblia and Trichomonas vaginalis.

4 , Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis.

5 t preparation and a culture method to detect Trichomonas vaginalis.

6 Trypanosoma brucei, Leishmania donovani, and Trichomonas vaginalis.

7 in one of the earliest diverging protozoans, Trichomonas vaginalis.

8 is specifically related to a homologue from Trichomonas vaginalis.

9 a, that represented by the parasitic protist Trichomonas vaginalis.

10 ctably transform the human-infective protist Trichomonas vaginalis.

11 ption of protein-coding genes of the protist Trichomonas vaginalis.

12 nscription factor in the protozoan parasite, Trichomonas vaginalis.

13 for Candida spp., Gardnerella vaginalis, and Trichomonas vaginalis.

14 ally transmitted infections (STIs) caused by Trichomonas vaginalis.

15 aginotropic extracellular protozoan parasite Trichomonas vaginalis.

16 Women were also tested for Trichomonas vaginalis.

17 sekeeping genes, to genetically characterize Trichomonas vaginalis.

18 bation of culture media for the detection of Trichomonas vaginalis.

19 terium Anabaena sp. (44%), and the protozoan Trichomonas vaginalis (46%), which targets its POR to an

20 Trichomonas vaginalis, a flagellated protozoan, is the a

21 In Trichomonas vaginalis, a Myb1 protein was previously dem

22 In Trichomonas vaginalis, a parabasalian flagellate thought

23 Among them, Trichomonas vaginalis, a parasite adapted to the human g

24 describe the genome sequence of the protist Trichomonas vaginalis, a sexually transmitted human path

25 there was some evidence of association with Trichomonas vaginalis (adjusted OR, 1.56; 95% CI, 1.00-2

26 d Entamoeba histolytica, and the parabasalid Trichomonas vaginalis all belong to Class II of FBAs and

27 ribed in the divergent unicellular eukaryote Trichomonas vaginalis, although genome analyses reveal t

28 The discovery that Trichomonas vaginalis, an early diverging protist that l

29 7,899 specimens submitted for live clinical Trichomonas vaginalis analyte-specific reagent (ASR) scr

30 o transcription-mediated amplification-based Trichomonas vaginalis analyte-specific-reagent (ASR) tes

31 s specific, since the related human parasite Trichomonas vaginalis and associated purified CPs did no

32 ption-mediated amplification (TMA) assay for Trichomonas vaginalis and BTUB FRET PCR, using self-obta

33 drial carrier family in the hydrogenosome of Trichomonas vaginalis and have shown that this protein,

34 icient in metronidazole-resistant strains of Trichomonas vaginalis and is thought to be necessary for

35 Additional Trichomonas vaginalis and Mycoplasma genitalium screenin

36 sence of a splicing apparatus in the protist Trichomonas vaginalis and show that RNA motifs found in

37 ent in the amitochondriate parasitic protist Trichomonas vaginalis and some but not all other trichom

38 Trichomonas vaginalis and viral pathogens (herpes simple

39 hlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis) and the E6/E7 mRNA of human papil

40 lastida (Leishmania major), the Parabasalia (Trichomonas vaginalis), and the Microsporidia (Vairimorp

41 hlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and bacterial vaginosis testing w

42 the pathogenic protozoa Giardia lamblia and Trichomonas vaginalis, and the bacterial pathogens Helic

43 the slime-mold Dictyostelium, the protozoan Trichomonas vaginalis, and the bacterium Burkholderia ps

44 ntamoeba fragilis, Pentatrichomonas hominis, Trichomonas vaginalis, and Trichomonas tenax.

45 The parasite he discovered was Trichomonas vaginalis; and, in collaboration with Foucau

46 ing Giardia lamblia, Leishmania species, and Trichomonas vaginalis are persistently infected with dsR

47 omonas vaginalis prevalence using the Aptima Trichomonas vaginalis assay (ATV; Gen-Probe) and the pre

48 ts of a commercial NAA test (GenProbe Aptima Trichomonas vaginalis assay; ATV) for T. vaginalis were

49 clinic for a new complaint were screened for Trichomonas vaginalis by culture and by PCR analysis of

50 on as well as to determine the prevalence of Trichomonas vaginalis by culture in a large and diverse

51 amplification tests (NAATs) for detection of Trichomonas vaginalis by vaginal swabs; NAATs for detect

52 clinic for a new complaint were screened for Trichomonas vaginalis by wet-preparation (wet-prep) micr

53 he three common organisms causing vaginitis: Trichomonas vaginalis, Candida species, and Gardnerella

54 The human-infective parasite Trichomonas vaginalis causes the most prevalent nonviral

55 The protozoan Trichomonas vaginalis colonizes the human urogenital tra

56 Trichomonas vaginalis colonizes the urogenital tract of

57 The extracellular parasite Trichomonas vaginalis contains a surface glycoconjugate

58 om Trypanosoma cruzi, Entamoeba histolytica, Trichomonas vaginalis, Cryptococcus neoformans, and Sacc

59 thral swabs were obtained at enrollment, for Trichomonas vaginalis culture; semen specimens were also

60 n of macaques with Chlamydia trachomatis and Trichomonas vaginalis decreases the prophylactic efficac

61 determine if secreted cysteine proteases of Trichomonas vaginalis degrade SLPI and render it nonfunc

62 condary test in improving the sensitivity of Trichomonas vaginalis detection in young women over that

63 This study compared two assays for Trichomonas vaginalis detection, Gen-Probe's transcripti

64 obe was designed and evaluated for detecting Trichomonas vaginalis DNA in a 5' nuclease (TaqMan) assa

65 polymerase chain reaction (PCR) analysis for Trichomonas vaginalis DNA.

66 Infection with Trichomonas vaginalis during pregnancy has been associat

67 The crystal structure of the oxidized Trichomonas vaginalis ferredoxin (Tvfd) showed a unique

68 odified medium to InPouch for the culture of Trichomonas vaginalis from pooled vaginal secretions.

69 Two genes coding for Trichomonas vaginalis glucokinase were isolated and sequ

70 ase (PPi-PFK) of the amitochondriate protist Trichomonas vaginalis has been purified.

71 The utility of TMA for detection of Trichomonas vaginalis has recently been described.

72 tica, Leishmania spp., Trypanosoma cruzi and Trichomonas vaginalis have genes encoding homologues of

73 Nucleic acid amplification tests for Trichomonas vaginalis have improved sensitivity for dete

74 plasma genitalium, Chlamydia trachomatis, or Trichomonas vaginalis in 10 patients (8%).

75 ydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in liquid-based cytology specimens

76 could also detect Mycoplasma genitalium and Trichomonas vaginalis in men and women reporting a histo

77 The impact of the viability of Trichomonas vaginalis in urine on wet mount, culture, an

78 Trichomonas vaginalis infected with a double-stranded RN

79 l SLPI levels have been correlated with both Trichomonas vaginalis infection and poor reproductive he

80 Trichomonas vaginalis infection in males has been largel

81 Trichomonas vaginalis infection in men is an important c

82 ed to wet mount and PCR for the diagnosis of Trichomonas vaginalis infection in women.

83 Trichomonas vaginalis infection is a sexually transmitte

84 Trichomonas vaginalis infection is estimated to be the m

85 The prevalence of Trichomonas vaginalis infection is highest in women with

86 Trichomonas vaginalis infection is highly prevalent worl

87 Trichomonas vaginalis infection is highly prevalent, may

88 Trichomonas vaginalis infection is the most prevalent no

89 omen in Mombasa, Kenya, to determine whether Trichomonas vaginalis infection was associated with an i

90 = 756 men), we identified 150 men (20%) with Trichomonas vaginalis infection, 358 men (47%) with HIV

91 ns related to the diagnosis and treatment of Trichomonas vaginalis infection, as well as the associat

92 esented regarding conditions associated with Trichomonas vaginalis infection, including human immunod

93 k women, being 30 to 40 years of age, recent Trichomonas vaginalis infection, primary or recurrent ge

94 infection, Chlamydia trachomatis infection, Trichomonas vaginalis infection, vulvovaginal candidiasi

95 eria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis infection.

96 ydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis infection.

97 Trichomonas vaginalis infections are usually asymptomati

98 eria gonorrhoeae, Mycoplasma genitalium, and Trichomonas vaginalis infections as well as the characte

99 tudy was to evaluate potential mechanisms of Trichomonas vaginalis involvement in human immunodeficie

100 Trichomonas vaginalis is a common sexually transmitted i

101 Trichomonas vaginalis is a highly divergent, unicellular

102 Trichomonas vaginalis is a parasite of the urogenital tr

103 Trichomonas vaginalis is a parasitic protozoan and the c

104 Trichomonas vaginalis is a parasitic protozoan purine au

105 Trichomonas vaginalis is a protist that causes the most

106 Trichomonas vaginalis is a protozoan parasite of humans

107 Trichomonas vaginalis is a unicellular microaerophilic e

108 Trichomonas vaginalis is an anaerobic protozoan parasite

109 Trichomonas vaginalis is an extracellular protozoan para

110 Trichomonas vaginalis is an important pathogen in both m

111 Trichomonas vaginalis is an underestimated sexually tran

112 Host parasitism by Trichomonas vaginalis is complex and in part mediated by

113 Host parasitism by Trichomonas vaginalis is complex, and the adhesion to va

114 from the sexually transmitted human parasite Trichomonas vaginalis is described.

115 The protist Trichomonas vaginalis is one of the most common human se

116 Trichomonas vaginalis is one of the most common nonviral

117 ecreted cysteine protease (CP) fraction from Trichomonas vaginalis is shown here to induce apoptosis

118 Trichomonas vaginalis is the agent of a highly prevalent

119 Trichomonas vaginalis is the most prevalent nonviral sex

120 Trichomonas vaginalis is the most prevalent nonviral sex

121 es inoculated with Chlamydia trachomatis and Trichomonas vaginalis (n = 9) or medium (controls; n = 7

122 With gap1 from Trichomonas vaginalis obtained earlier, the data include

123 unusual case of extragenital infection with Trichomonas vaginalis of the conjunctiva of a 32-year-ol

124 rican women who used drugs were screened for Trichomonas vaginalis on > or =2 occasions between March

125 230) performed rapid point-of-care tests for Trichomonas vaginalis on self-collected vaginal swabs.

126 ated in patients concomitantly infected with Trichomonas vaginalis or Chlamydia trachomatis in additi

127 Women infected with Neisseria gonorrhoeae, Trichomonas vaginalis, or Chlamydia trachomatis had high

128 en, infections with Neisseria gonorrhoeae or Trichomonas vaginalis, or long-term follow-up.

129 ins AP65, AP51, AP33 and AP23 synthesized by Trichomonas vaginalis organisms in high iron play a role

130 culture and evaluated their interaction with Trichomonas vaginalis parasites to complement previous s

131 Trichomonas vaginalis PCR using reagents from a commerci

132 fungal pathogens, as well as protozoa, e.g., Trichomonas vaginalis, Plasmodium berghei, and sporozoit

133 Our aim was to determine Trichomonas vaginalis prevalence using the Aptima Tricho

134 Trichomonas vaginalis produces soluble factors that have

135 the genome databases for Giardia lamblia and Trichomonas vaginalis, respectively, and represent the l

136 e (rSAHH) cloned from Pseudomonas putida and Trichomonas vaginalis, respectively.

137 binding protein from the primitive eukaryote Trichomonas vaginalis reveals how a single protein can o

138 s the gold standard for clinical culture for Trichomonas vaginalis screening.

139 Our analyses of the Trichomonas vaginalis SCS sequences also confirmed the m

140 Trichomonas vaginalis secretes putrescine that is readil

141 ydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis Sequencing was used to assess macr

142 A related human trichomonad, Trichomonas vaginalis, showed no cytotoxic effects, indi

143 the amitochondrial Entamoeba histolytica and Trichomonas vaginalis species were analyzed.

144 The InPouch Trichomonas vaginalis test is the gold standard for clin

145 aginalis were compared with the Affirm VPIII Trichomonas vaginalis test.

146 hydrogenosome-bearing, unicellular eukaryote Trichomonas vaginalis, that contains the active site mot

147 Trichomonas vaginalis, the causative agent for human tri

148 e medically important parasites: the protist Trichomonas vaginalis, the hard tick Ixodes ricinus, and

149 2 (HSV-2), syphilis, chlamydia, gonorrhoea, Trichomonas vaginalis (together defined as 'any STI') an

150 iterature has reported increased accuracy of Trichomonas vaginalis transcription-mediated amplificati

151 oth prevalent and persistent infections with Trichomonas vaginalis (TV) are common.

152 omatis (CT), Mycoplasma genitalium (MG), and Trichomonas vaginalis (TV) are sexually transmitted infe

153 Trichomonas vaginalis (TV) can be infected with double-s

154 n is affected by bacterial vaginosis (BV) or Trichomonas vaginalis (TV) infection has not been adequa

155 Trichomonas vaginalis (TV) is the most common nonviral s

156 Ureaplasma urealyticum biovar 2 (UU-2), and Trichomonas vaginalis (TV) using nucleic acid amplificat

157 sis (BV), vulvovaginal candidiasis (VVC), or Trichomonas vaginalis (TV), were randomly assigned to re

158 xidized form of the [2Fe-2S] ferredoxin from Trichomonas vaginalis (TvFd) are presented.

159 s simplex virus 2 infection, genital ulcers, Trichomonas vaginalis, vaginitis or cervicitis, and male

160 ydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis via commercial transcription-media

161 LV was found to be more thermoresistant than Trichomonas vaginalis virus 1, but no specific protein m

162 iruses, including Leishmania RNA viruses and Trichomonas vaginalis viruses.

163 GPI of the parabasalid Trichomonas vaginalis was also sequenced.

164 ransport medium to maintain the viability of Trichomonas vaginalis was determined by comparing transp

165 CR assay, using primers against pfoB gene of Trichomonas vaginalis, was developed and evaluated using

166 DNA detection, but Chlamydia trachomatis and Trichomonas vaginalis were not.

167 eria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis were performed.

168 Trichomonas vaginalis, which causes the most common nonv

169 equences in the protists Giardia lamblia and Trichomonas vaginalis, which may represent the deepest k

170 tein-encoding genes in the parasitic protist Trichomonas vaginalis, which represents one of the deepe